<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVO6" lang="spa" raw_text_char_length="1621" raw_text_md5="8b1435ae40a8abb7e107485510d5f6c0" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="62" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Interferon-α2b May Shorten Viral Shedding Duration in COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="14" id="token-0-0" morph="none" pos="unknown" start_char="1">Interferon-α2b</TOKEN>
<TOKEN end_char="18" id="token-0-1" morph="none" pos="word" start_char="16">May</TOKEN>
<TOKEN end_char="26" id="token-0-2" morph="none" pos="word" start_char="20">Shorten</TOKEN>
<TOKEN end_char="32" id="token-0-3" morph="none" pos="word" start_char="28">Viral</TOKEN>
<TOKEN end_char="41" id="token-0-4" morph="none" pos="word" start_char="34">Shedding</TOKEN>
<TOKEN end_char="50" id="token-0-5" morph="none" pos="word" start_char="43">Duration</TOKEN>
<TOKEN end_char="53" id="token-0-6" morph="none" pos="word" start_char="52">in</TOKEN>
<TOKEN end_char="62" id="token-0-7" morph="none" pos="unknown" start_char="55">COVID-19</TOKEN>
</SEG>
<SEG end_char="266" id="segment-1" start_char="67">
<ORIGINAL_TEXT>FRIDAY, May 15, 2020 (HealthDay News) -- Interferon (IFN)-α2b therapy seems to shorten the duration of viral shedding in hospitalized COVID-19 patients, according to a study published online May 15 in</ORIGINAL_TEXT>
<TOKEN end_char="72" id="token-1-0" morph="none" pos="word" start_char="67">FRIDAY</TOKEN>
<TOKEN end_char="73" id="token-1-1" morph="none" pos="punct" start_char="73">,</TOKEN>
<TOKEN end_char="77" id="token-1-2" morph="none" pos="word" start_char="75">May</TOKEN>
<TOKEN end_char="80" id="token-1-3" morph="none" pos="word" start_char="79">15</TOKEN>
<TOKEN end_char="81" id="token-1-4" morph="none" pos="punct" start_char="81">,</TOKEN>
<TOKEN end_char="86" id="token-1-5" morph="none" pos="word" start_char="83">2020</TOKEN>
<TOKEN end_char="88" id="token-1-6" morph="none" pos="punct" start_char="88">(</TOKEN>
<TOKEN end_char="97" id="token-1-7" morph="none" pos="word" start_char="89">HealthDay</TOKEN>
<TOKEN end_char="102" id="token-1-8" morph="none" pos="word" start_char="99">News</TOKEN>
<TOKEN end_char="103" id="token-1-9" morph="none" pos="punct" start_char="103">)</TOKEN>
<TOKEN end_char="106" id="token-1-10" morph="none" pos="punct" start_char="105">--</TOKEN>
<TOKEN end_char="117" id="token-1-11" morph="none" pos="word" start_char="108">Interferon</TOKEN>
<TOKEN end_char="119" id="token-1-12" morph="none" pos="punct" start_char="119">(</TOKEN>
<TOKEN end_char="127" id="token-1-13" morph="none" pos="unknown" start_char="120">IFN)-α2b</TOKEN>
<TOKEN end_char="135" id="token-1-14" morph="none" pos="word" start_char="129">therapy</TOKEN>
<TOKEN end_char="141" id="token-1-15" morph="none" pos="word" start_char="137">seems</TOKEN>
<TOKEN end_char="144" id="token-1-16" morph="none" pos="word" start_char="143">to</TOKEN>
<TOKEN end_char="152" id="token-1-17" morph="none" pos="word" start_char="146">shorten</TOKEN>
<TOKEN end_char="156" id="token-1-18" morph="none" pos="word" start_char="154">the</TOKEN>
<TOKEN end_char="165" id="token-1-19" morph="none" pos="word" start_char="158">duration</TOKEN>
<TOKEN end_char="168" id="token-1-20" morph="none" pos="word" start_char="167">of</TOKEN>
<TOKEN end_char="174" id="token-1-21" morph="none" pos="word" start_char="170">viral</TOKEN>
<TOKEN end_char="183" id="token-1-22" morph="none" pos="word" start_char="176">shedding</TOKEN>
<TOKEN end_char="186" id="token-1-23" morph="none" pos="word" start_char="185">in</TOKEN>
<TOKEN end_char="199" id="token-1-24" morph="none" pos="word" start_char="188">hospitalized</TOKEN>
<TOKEN end_char="208" id="token-1-25" morph="none" pos="unknown" start_char="201">COVID-19</TOKEN>
<TOKEN end_char="217" id="token-1-26" morph="none" pos="word" start_char="210">patients</TOKEN>
<TOKEN end_char="218" id="token-1-27" morph="none" pos="punct" start_char="218">,</TOKEN>
<TOKEN end_char="228" id="token-1-28" morph="none" pos="word" start_char="220">according</TOKEN>
<TOKEN end_char="231" id="token-1-29" morph="none" pos="word" start_char="230">to</TOKEN>
<TOKEN end_char="233" id="token-1-30" morph="none" pos="word" start_char="233">a</TOKEN>
<TOKEN end_char="239" id="token-1-31" morph="none" pos="word" start_char="235">study</TOKEN>
<TOKEN end_char="249" id="token-1-32" morph="none" pos="word" start_char="241">published</TOKEN>
<TOKEN end_char="256" id="token-1-33" morph="none" pos="word" start_char="251">online</TOKEN>
<TOKEN end_char="260" id="token-1-34" morph="none" pos="word" start_char="258">May</TOKEN>
<TOKEN end_char="263" id="token-1-35" morph="none" pos="word" start_char="262">15</TOKEN>
<TOKEN end_char="266" id="token-1-36" morph="none" pos="word" start_char="265">in</TOKEN>
</SEG>
<SEG end_char="291" id="segment-2" start_char="269">
<ORIGINAL_TEXT>Frontiers in Immunology</ORIGINAL_TEXT>
<TOKEN end_char="277" id="token-2-0" morph="none" pos="word" start_char="269">Frontiers</TOKEN>
<TOKEN end_char="280" id="token-2-1" morph="none" pos="word" start_char="279">in</TOKEN>
<TOKEN end_char="291" id="token-2-2" morph="none" pos="word" start_char="282">Immunology</TOKEN>
</SEG>
<SEG end_char="294" id="segment-3" start_char="294">
<ORIGINAL_TEXT>.</ORIGINAL_TEXT>
<TOKEN end_char="294" id="token-3-0" morph="none" pos="punct" start_char="294">.</TOKEN>
</SEG>
<SEG end_char="559" id="segment-4" start_char="297">
<ORIGINAL_TEXT>Qiong Zhou, M.D., Ph.D., from the Union Hospital Tongji Medical College and Huazhong University of Science and Technology in Wuhan, China, and colleagues describe the effects of treatment with IFN-α2b in a cohort of 77 adults hospitalized with confirmed COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="301" id="token-4-0" morph="none" pos="word" start_char="297">Qiong</TOKEN>
<TOKEN end_char="306" id="token-4-1" morph="none" pos="word" start_char="303">Zhou</TOKEN>
<TOKEN end_char="307" id="token-4-2" morph="none" pos="punct" start_char="307">,</TOKEN>
<TOKEN end_char="311" id="token-4-3" morph="none" pos="unknown" start_char="309">M.D</TOKEN>
<TOKEN end_char="313" id="token-4-4" morph="none" pos="punct" start_char="312">.,</TOKEN>
<TOKEN end_char="318" id="token-4-5" morph="none" pos="unknown" start_char="315">Ph.D</TOKEN>
<TOKEN end_char="320" id="token-4-6" morph="none" pos="punct" start_char="319">.,</TOKEN>
<TOKEN end_char="325" id="token-4-7" morph="none" pos="word" start_char="322">from</TOKEN>
<TOKEN end_char="329" id="token-4-8" morph="none" pos="word" start_char="327">the</TOKEN>
<TOKEN end_char="335" id="token-4-9" morph="none" pos="word" start_char="331">Union</TOKEN>
<TOKEN end_char="344" id="token-4-10" morph="none" pos="word" start_char="337">Hospital</TOKEN>
<TOKEN end_char="351" id="token-4-11" morph="none" pos="word" start_char="346">Tongji</TOKEN>
<TOKEN end_char="359" id="token-4-12" morph="none" pos="word" start_char="353">Medical</TOKEN>
<TOKEN end_char="367" id="token-4-13" morph="none" pos="word" start_char="361">College</TOKEN>
<TOKEN end_char="371" id="token-4-14" morph="none" pos="word" start_char="369">and</TOKEN>
<TOKEN end_char="380" id="token-4-15" morph="none" pos="word" start_char="373">Huazhong</TOKEN>
<TOKEN end_char="391" id="token-4-16" morph="none" pos="word" start_char="382">University</TOKEN>
<TOKEN end_char="394" id="token-4-17" morph="none" pos="word" start_char="393">of</TOKEN>
<TOKEN end_char="402" id="token-4-18" morph="none" pos="word" start_char="396">Science</TOKEN>
<TOKEN end_char="406" id="token-4-19" morph="none" pos="word" start_char="404">and</TOKEN>
<TOKEN end_char="417" id="token-4-20" morph="none" pos="word" start_char="408">Technology</TOKEN>
<TOKEN end_char="420" id="token-4-21" morph="none" pos="word" start_char="419">in</TOKEN>
<TOKEN end_char="426" id="token-4-22" morph="none" pos="word" start_char="422">Wuhan</TOKEN>
<TOKEN end_char="427" id="token-4-23" morph="none" pos="punct" start_char="427">,</TOKEN>
<TOKEN end_char="433" id="token-4-24" morph="none" pos="word" start_char="429">China</TOKEN>
<TOKEN end_char="434" id="token-4-25" morph="none" pos="punct" start_char="434">,</TOKEN>
<TOKEN end_char="438" id="token-4-26" morph="none" pos="word" start_char="436">and</TOKEN>
<TOKEN end_char="449" id="token-4-27" morph="none" pos="word" start_char="440">colleagues</TOKEN>
<TOKEN end_char="458" id="token-4-28" morph="none" pos="word" start_char="451">describe</TOKEN>
<TOKEN end_char="462" id="token-4-29" morph="none" pos="word" start_char="460">the</TOKEN>
<TOKEN end_char="470" id="token-4-30" morph="none" pos="word" start_char="464">effects</TOKEN>
<TOKEN end_char="473" id="token-4-31" morph="none" pos="word" start_char="472">of</TOKEN>
<TOKEN end_char="483" id="token-4-32" morph="none" pos="word" start_char="475">treatment</TOKEN>
<TOKEN end_char="488" id="token-4-33" morph="none" pos="word" start_char="485">with</TOKEN>
<TOKEN end_char="496" id="token-4-34" morph="none" pos="unknown" start_char="490">IFN-α2b</TOKEN>
<TOKEN end_char="499" id="token-4-35" morph="none" pos="word" start_char="498">in</TOKEN>
<TOKEN end_char="501" id="token-4-36" morph="none" pos="word" start_char="501">a</TOKEN>
<TOKEN end_char="508" id="token-4-37" morph="none" pos="word" start_char="503">cohort</TOKEN>
<TOKEN end_char="511" id="token-4-38" morph="none" pos="word" start_char="510">of</TOKEN>
<TOKEN end_char="514" id="token-4-39" morph="none" pos="word" start_char="513">77</TOKEN>
<TOKEN end_char="521" id="token-4-40" morph="none" pos="word" start_char="516">adults</TOKEN>
<TOKEN end_char="534" id="token-4-41" morph="none" pos="word" start_char="523">hospitalized</TOKEN>
<TOKEN end_char="539" id="token-4-42" morph="none" pos="word" start_char="536">with</TOKEN>
<TOKEN end_char="549" id="token-4-43" morph="none" pos="word" start_char="541">confirmed</TOKEN>
<TOKEN end_char="558" id="token-4-44" morph="none" pos="unknown" start_char="551">COVID-19</TOKEN>
<TOKEN end_char="559" id="token-4-45" morph="none" pos="punct" start_char="559">.</TOKEN>
</SEG>
<SEG end_char="712" id="segment-5" start_char="561">
<ORIGINAL_TEXT>Patients were treated with nebulized IFN-α2b, umifenovir (Arbidol; currently only used in Russia and China) or a combination of IFN-α2b plus umifenovir.</ORIGINAL_TEXT>
<TOKEN end_char="568" id="token-5-0" morph="none" pos="word" start_char="561">Patients</TOKEN>
<TOKEN end_char="573" id="token-5-1" morph="none" pos="word" start_char="570">were</TOKEN>
<TOKEN end_char="581" id="token-5-2" morph="none" pos="word" start_char="575">treated</TOKEN>
<TOKEN end_char="586" id="token-5-3" morph="none" pos="word" start_char="583">with</TOKEN>
<TOKEN end_char="596" id="token-5-4" morph="none" pos="word" start_char="588">nebulized</TOKEN>
<TOKEN end_char="604" id="token-5-5" morph="none" pos="unknown" start_char="598">IFN-α2b</TOKEN>
<TOKEN end_char="605" id="token-5-6" morph="none" pos="punct" start_char="605">,</TOKEN>
<TOKEN end_char="616" id="token-5-7" morph="none" pos="word" start_char="607">umifenovir</TOKEN>
<TOKEN end_char="618" id="token-5-8" morph="none" pos="punct" start_char="618">(</TOKEN>
<TOKEN end_char="625" id="token-5-9" morph="none" pos="word" start_char="619">Arbidol</TOKEN>
<TOKEN end_char="626" id="token-5-10" morph="none" pos="punct" start_char="626">;</TOKEN>
<TOKEN end_char="636" id="token-5-11" morph="none" pos="word" start_char="628">currently</TOKEN>
<TOKEN end_char="641" id="token-5-12" morph="none" pos="word" start_char="638">only</TOKEN>
<TOKEN end_char="646" id="token-5-13" morph="none" pos="word" start_char="643">used</TOKEN>
<TOKEN end_char="649" id="token-5-14" morph="none" pos="word" start_char="648">in</TOKEN>
<TOKEN end_char="656" id="token-5-15" morph="none" pos="word" start_char="651">Russia</TOKEN>
<TOKEN end_char="660" id="token-5-16" morph="none" pos="word" start_char="658">and</TOKEN>
<TOKEN end_char="666" id="token-5-17" morph="none" pos="word" start_char="662">China</TOKEN>
<TOKEN end_char="667" id="token-5-18" morph="none" pos="punct" start_char="667">)</TOKEN>
<TOKEN end_char="670" id="token-5-19" morph="none" pos="word" start_char="669">or</TOKEN>
<TOKEN end_char="672" id="token-5-20" morph="none" pos="word" start_char="672">a</TOKEN>
<TOKEN end_char="684" id="token-5-21" morph="none" pos="word" start_char="674">combination</TOKEN>
<TOKEN end_char="687" id="token-5-22" morph="none" pos="word" start_char="686">of</TOKEN>
<TOKEN end_char="695" id="token-5-23" morph="none" pos="unknown" start_char="689">IFN-α2b</TOKEN>
<TOKEN end_char="700" id="token-5-24" morph="none" pos="word" start_char="697">plus</TOKEN>
<TOKEN end_char="711" id="token-5-25" morph="none" pos="word" start_char="702">umifenovir</TOKEN>
<TOKEN end_char="712" id="token-5-26" morph="none" pos="punct" start_char="712">.</TOKEN>
</SEG>
<SEG end_char="915" id="segment-6" start_char="714">
<ORIGINAL_TEXT>For each patient, serial severe acute respiratory syndrome coronavirus 2 testing along with hematological measurements, temperature, and blood saturation levels were recorded during their hospital stay.</ORIGINAL_TEXT>
<TOKEN end_char="716" id="token-6-0" morph="none" pos="word" start_char="714">For</TOKEN>
<TOKEN end_char="721" id="token-6-1" morph="none" pos="word" start_char="718">each</TOKEN>
<TOKEN end_char="729" id="token-6-2" morph="none" pos="word" start_char="723">patient</TOKEN>
<TOKEN end_char="730" id="token-6-3" morph="none" pos="punct" start_char="730">,</TOKEN>
<TOKEN end_char="737" id="token-6-4" morph="none" pos="word" start_char="732">serial</TOKEN>
<TOKEN end_char="744" id="token-6-5" morph="none" pos="word" start_char="739">severe</TOKEN>
<TOKEN end_char="750" id="token-6-6" morph="none" pos="word" start_char="746">acute</TOKEN>
<TOKEN end_char="762" id="token-6-7" morph="none" pos="word" start_char="752">respiratory</TOKEN>
<TOKEN end_char="771" id="token-6-8" morph="none" pos="word" start_char="764">syndrome</TOKEN>
<TOKEN end_char="783" id="token-6-9" morph="none" pos="word" start_char="773">coronavirus</TOKEN>
<TOKEN end_char="785" id="token-6-10" morph="none" pos="word" start_char="785">2</TOKEN>
<TOKEN end_char="793" id="token-6-11" morph="none" pos="word" start_char="787">testing</TOKEN>
<TOKEN end_char="799" id="token-6-12" morph="none" pos="word" start_char="795">along</TOKEN>
<TOKEN end_char="804" id="token-6-13" morph="none" pos="word" start_char="801">with</TOKEN>
<TOKEN end_char="818" id="token-6-14" morph="none" pos="word" start_char="806">hematological</TOKEN>
<TOKEN end_char="831" id="token-6-15" morph="none" pos="word" start_char="820">measurements</TOKEN>
<TOKEN end_char="832" id="token-6-16" morph="none" pos="punct" start_char="832">,</TOKEN>
<TOKEN end_char="844" id="token-6-17" morph="none" pos="word" start_char="834">temperature</TOKEN>
<TOKEN end_char="845" id="token-6-18" morph="none" pos="punct" start_char="845">,</TOKEN>
<TOKEN end_char="849" id="token-6-19" morph="none" pos="word" start_char="847">and</TOKEN>
<TOKEN end_char="855" id="token-6-20" morph="none" pos="word" start_char="851">blood</TOKEN>
<TOKEN end_char="866" id="token-6-21" morph="none" pos="word" start_char="857">saturation</TOKEN>
<TOKEN end_char="873" id="token-6-22" morph="none" pos="word" start_char="868">levels</TOKEN>
<TOKEN end_char="878" id="token-6-23" morph="none" pos="word" start_char="875">were</TOKEN>
<TOKEN end_char="887" id="token-6-24" morph="none" pos="word" start_char="880">recorded</TOKEN>
<TOKEN end_char="894" id="token-6-25" morph="none" pos="word" start_char="889">during</TOKEN>
<TOKEN end_char="900" id="token-6-26" morph="none" pos="word" start_char="896">their</TOKEN>
<TOKEN end_char="909" id="token-6-27" morph="none" pos="word" start_char="902">hospital</TOKEN>
<TOKEN end_char="914" id="token-6-28" morph="none" pos="word" start_char="911">stay</TOKEN>
<TOKEN end_char="915" id="token-6-29" morph="none" pos="punct" start_char="915">.</TOKEN>
</SEG>
<SEG end_char="1220" id="segment-7" start_char="918">
<ORIGINAL_TEXT>The researchers found that the duration of detectable virus in the upper respiratory tract was significantly reduced with treatment with IFN-α2b with or without umifenovir; in parallel, the duration of elevated blood levels for the inflammatory markers interleukin-6 and C-reactive protein were reduced.</ORIGINAL_TEXT>
<TOKEN end_char="920" id="token-7-0" morph="none" pos="word" start_char="918">The</TOKEN>
<TOKEN end_char="932" id="token-7-1" morph="none" pos="word" start_char="922">researchers</TOKEN>
<TOKEN end_char="938" id="token-7-2" morph="none" pos="word" start_char="934">found</TOKEN>
<TOKEN end_char="943" id="token-7-3" morph="none" pos="word" start_char="940">that</TOKEN>
<TOKEN end_char="947" id="token-7-4" morph="none" pos="word" start_char="945">the</TOKEN>
<TOKEN end_char="956" id="token-7-5" morph="none" pos="word" start_char="949">duration</TOKEN>
<TOKEN end_char="959" id="token-7-6" morph="none" pos="word" start_char="958">of</TOKEN>
<TOKEN end_char="970" id="token-7-7" morph="none" pos="word" start_char="961">detectable</TOKEN>
<TOKEN end_char="976" id="token-7-8" morph="none" pos="word" start_char="972">virus</TOKEN>
<TOKEN end_char="979" id="token-7-9" morph="none" pos="word" start_char="978">in</TOKEN>
<TOKEN end_char="983" id="token-7-10" morph="none" pos="word" start_char="981">the</TOKEN>
<TOKEN end_char="989" id="token-7-11" morph="none" pos="word" start_char="985">upper</TOKEN>
<TOKEN end_char="1001" id="token-7-12" morph="none" pos="word" start_char="991">respiratory</TOKEN>
<TOKEN end_char="1007" id="token-7-13" morph="none" pos="word" start_char="1003">tract</TOKEN>
<TOKEN end_char="1011" id="token-7-14" morph="none" pos="word" start_char="1009">was</TOKEN>
<TOKEN end_char="1025" id="token-7-15" morph="none" pos="word" start_char="1013">significantly</TOKEN>
<TOKEN end_char="1033" id="token-7-16" morph="none" pos="word" start_char="1027">reduced</TOKEN>
<TOKEN end_char="1038" id="token-7-17" morph="none" pos="word" start_char="1035">with</TOKEN>
<TOKEN end_char="1048" id="token-7-18" morph="none" pos="word" start_char="1040">treatment</TOKEN>
<TOKEN end_char="1053" id="token-7-19" morph="none" pos="word" start_char="1050">with</TOKEN>
<TOKEN end_char="1061" id="token-7-20" morph="none" pos="unknown" start_char="1055">IFN-α2b</TOKEN>
<TOKEN end_char="1066" id="token-7-21" morph="none" pos="word" start_char="1063">with</TOKEN>
<TOKEN end_char="1069" id="token-7-22" morph="none" pos="word" start_char="1068">or</TOKEN>
<TOKEN end_char="1077" id="token-7-23" morph="none" pos="word" start_char="1071">without</TOKEN>
<TOKEN end_char="1088" id="token-7-24" morph="none" pos="word" start_char="1079">umifenovir</TOKEN>
<TOKEN end_char="1089" id="token-7-25" morph="none" pos="punct" start_char="1089">;</TOKEN>
<TOKEN end_char="1092" id="token-7-26" morph="none" pos="word" start_char="1091">in</TOKEN>
<TOKEN end_char="1101" id="token-7-27" morph="none" pos="word" start_char="1094">parallel</TOKEN>
<TOKEN end_char="1102" id="token-7-28" morph="none" pos="punct" start_char="1102">,</TOKEN>
<TOKEN end_char="1106" id="token-7-29" morph="none" pos="word" start_char="1104">the</TOKEN>
<TOKEN end_char="1115" id="token-7-30" morph="none" pos="word" start_char="1108">duration</TOKEN>
<TOKEN end_char="1118" id="token-7-31" morph="none" pos="word" start_char="1117">of</TOKEN>
<TOKEN end_char="1127" id="token-7-32" morph="none" pos="word" start_char="1120">elevated</TOKEN>
<TOKEN end_char="1133" id="token-7-33" morph="none" pos="word" start_char="1129">blood</TOKEN>
<TOKEN end_char="1140" id="token-7-34" morph="none" pos="word" start_char="1135">levels</TOKEN>
<TOKEN end_char="1144" id="token-7-35" morph="none" pos="word" start_char="1142">for</TOKEN>
<TOKEN end_char="1148" id="token-7-36" morph="none" pos="word" start_char="1146">the</TOKEN>
<TOKEN end_char="1161" id="token-7-37" morph="none" pos="word" start_char="1150">inflammatory</TOKEN>
<TOKEN end_char="1169" id="token-7-38" morph="none" pos="word" start_char="1163">markers</TOKEN>
<TOKEN end_char="1183" id="token-7-39" morph="none" pos="unknown" start_char="1171">interleukin-6</TOKEN>
<TOKEN end_char="1187" id="token-7-40" morph="none" pos="word" start_char="1185">and</TOKEN>
<TOKEN end_char="1198" id="token-7-41" morph="none" pos="unknown" start_char="1189">C-reactive</TOKEN>
<TOKEN end_char="1206" id="token-7-42" morph="none" pos="word" start_char="1200">protein</TOKEN>
<TOKEN end_char="1211" id="token-7-43" morph="none" pos="word" start_char="1208">were</TOKEN>
<TOKEN end_char="1219" id="token-7-44" morph="none" pos="word" start_char="1213">reduced</TOKEN>
<TOKEN end_char="1220" id="token-7-45" morph="none" pos="punct" start_char="1220">.</TOKEN>
</SEG>
<SEG end_char="1403" id="segment-8" start_char="1223">
<ORIGINAL_TEXT>"To our knowledge, the findings presented here are the first to suggest therapeutic efficacy in COVID-19 disease of IFN-α2b, an available antiviral intervention," the authors write.</ORIGINAL_TEXT>
<TOKEN end_char="1223" id="token-8-0" morph="none" pos="punct" start_char="1223">"</TOKEN>
<TOKEN end_char="1225" id="token-8-1" morph="none" pos="word" start_char="1224">To</TOKEN>
<TOKEN end_char="1229" id="token-8-2" morph="none" pos="word" start_char="1227">our</TOKEN>
<TOKEN end_char="1239" id="token-8-3" morph="none" pos="word" start_char="1231">knowledge</TOKEN>
<TOKEN end_char="1240" id="token-8-4" morph="none" pos="punct" start_char="1240">,</TOKEN>
<TOKEN end_char="1244" id="token-8-5" morph="none" pos="word" start_char="1242">the</TOKEN>
<TOKEN end_char="1253" id="token-8-6" morph="none" pos="word" start_char="1246">findings</TOKEN>
<TOKEN end_char="1263" id="token-8-7" morph="none" pos="word" start_char="1255">presented</TOKEN>
<TOKEN end_char="1268" id="token-8-8" morph="none" pos="word" start_char="1265">here</TOKEN>
<TOKEN end_char="1272" id="token-8-9" morph="none" pos="word" start_char="1270">are</TOKEN>
<TOKEN end_char="1276" id="token-8-10" morph="none" pos="word" start_char="1274">the</TOKEN>
<TOKEN end_char="1282" id="token-8-11" morph="none" pos="word" start_char="1278">first</TOKEN>
<TOKEN end_char="1285" id="token-8-12" morph="none" pos="word" start_char="1284">to</TOKEN>
<TOKEN end_char="1293" id="token-8-13" morph="none" pos="word" start_char="1287">suggest</TOKEN>
<TOKEN end_char="1305" id="token-8-14" morph="none" pos="word" start_char="1295">therapeutic</TOKEN>
<TOKEN end_char="1314" id="token-8-15" morph="none" pos="word" start_char="1307">efficacy</TOKEN>
<TOKEN end_char="1317" id="token-8-16" morph="none" pos="word" start_char="1316">in</TOKEN>
<TOKEN end_char="1326" id="token-8-17" morph="none" pos="unknown" start_char="1319">COVID-19</TOKEN>
<TOKEN end_char="1334" id="token-8-18" morph="none" pos="word" start_char="1328">disease</TOKEN>
<TOKEN end_char="1337" id="token-8-19" morph="none" pos="word" start_char="1336">of</TOKEN>
<TOKEN end_char="1345" id="token-8-20" morph="none" pos="unknown" start_char="1339">IFN-α2b</TOKEN>
<TOKEN end_char="1346" id="token-8-21" morph="none" pos="punct" start_char="1346">,</TOKEN>
<TOKEN end_char="1349" id="token-8-22" morph="none" pos="word" start_char="1348">an</TOKEN>
<TOKEN end_char="1359" id="token-8-23" morph="none" pos="word" start_char="1351">available</TOKEN>
<TOKEN end_char="1369" id="token-8-24" morph="none" pos="word" start_char="1361">antiviral</TOKEN>
<TOKEN end_char="1382" id="token-8-25" morph="none" pos="word" start_char="1371">intervention</TOKEN>
<TOKEN end_char="1384" id="token-8-26" morph="none" pos="punct" start_char="1383">,"</TOKEN>
<TOKEN end_char="1388" id="token-8-27" morph="none" pos="word" start_char="1386">the</TOKEN>
<TOKEN end_char="1396" id="token-8-28" morph="none" pos="word" start_char="1390">authors</TOKEN>
<TOKEN end_char="1402" id="token-8-29" morph="none" pos="word" start_char="1398">write</TOKEN>
<TOKEN end_char="1403" id="token-8-30" morph="none" pos="punct" start_char="1403">.</TOKEN>
</SEG>
<SEG end_char="1617" id="segment-9" start_char="1405">
<ORIGINAL_TEXT>"Beyond clinical benefit to the individual patient, treatment with IFN-α2b may also benefit public health measures aimed at slowing the tide of this pandemic, in that duration of viral shedding appears shortened."</ORIGINAL_TEXT>
<TOKEN end_char="1405" id="token-9-0" morph="none" pos="punct" start_char="1405">"</TOKEN>
<TOKEN end_char="1411" id="token-9-1" morph="none" pos="word" start_char="1406">Beyond</TOKEN>
<TOKEN end_char="1420" id="token-9-2" morph="none" pos="word" start_char="1413">clinical</TOKEN>
<TOKEN end_char="1428" id="token-9-3" morph="none" pos="word" start_char="1422">benefit</TOKEN>
<TOKEN end_char="1431" id="token-9-4" morph="none" pos="word" start_char="1430">to</TOKEN>
<TOKEN end_char="1435" id="token-9-5" morph="none" pos="word" start_char="1433">the</TOKEN>
<TOKEN end_char="1446" id="token-9-6" morph="none" pos="word" start_char="1437">individual</TOKEN>
<TOKEN end_char="1454" id="token-9-7" morph="none" pos="word" start_char="1448">patient</TOKEN>
<TOKEN end_char="1455" id="token-9-8" morph="none" pos="punct" start_char="1455">,</TOKEN>
<TOKEN end_char="1465" id="token-9-9" morph="none" pos="word" start_char="1457">treatment</TOKEN>
<TOKEN end_char="1470" id="token-9-10" morph="none" pos="word" start_char="1467">with</TOKEN>
<TOKEN end_char="1478" id="token-9-11" morph="none" pos="unknown" start_char="1472">IFN-α2b</TOKEN>
<TOKEN end_char="1482" id="token-9-12" morph="none" pos="word" start_char="1480">may</TOKEN>
<TOKEN end_char="1487" id="token-9-13" morph="none" pos="word" start_char="1484">also</TOKEN>
<TOKEN end_char="1495" id="token-9-14" morph="none" pos="word" start_char="1489">benefit</TOKEN>
<TOKEN end_char="1502" id="token-9-15" morph="none" pos="word" start_char="1497">public</TOKEN>
<TOKEN end_char="1509" id="token-9-16" morph="none" pos="word" start_char="1504">health</TOKEN>
<TOKEN end_char="1518" id="token-9-17" morph="none" pos="word" start_char="1511">measures</TOKEN>
<TOKEN end_char="1524" id="token-9-18" morph="none" pos="word" start_char="1520">aimed</TOKEN>
<TOKEN end_char="1527" id="token-9-19" morph="none" pos="word" start_char="1526">at</TOKEN>
<TOKEN end_char="1535" id="token-9-20" morph="none" pos="word" start_char="1529">slowing</TOKEN>
<TOKEN end_char="1539" id="token-9-21" morph="none" pos="word" start_char="1537">the</TOKEN>
<TOKEN end_char="1544" id="token-9-22" morph="none" pos="word" start_char="1541">tide</TOKEN>
<TOKEN end_char="1547" id="token-9-23" morph="none" pos="word" start_char="1546">of</TOKEN>
<TOKEN end_char="1552" id="token-9-24" morph="none" pos="word" start_char="1549">this</TOKEN>
<TOKEN end_char="1561" id="token-9-25" morph="none" pos="word" start_char="1554">pandemic</TOKEN>
<TOKEN end_char="1562" id="token-9-26" morph="none" pos="punct" start_char="1562">,</TOKEN>
<TOKEN end_char="1565" id="token-9-27" morph="none" pos="word" start_char="1564">in</TOKEN>
<TOKEN end_char="1570" id="token-9-28" morph="none" pos="word" start_char="1567">that</TOKEN>
<TOKEN end_char="1579" id="token-9-29" morph="none" pos="word" start_char="1572">duration</TOKEN>
<TOKEN end_char="1582" id="token-9-30" morph="none" pos="word" start_char="1581">of</TOKEN>
<TOKEN end_char="1588" id="token-9-31" morph="none" pos="word" start_char="1584">viral</TOKEN>
<TOKEN end_char="1597" id="token-9-32" morph="none" pos="word" start_char="1590">shedding</TOKEN>
<TOKEN end_char="1605" id="token-9-33" morph="none" pos="word" start_char="1599">appears</TOKEN>
<TOKEN end_char="1615" id="token-9-34" morph="none" pos="word" start_char="1607">shortened</TOKEN>
<TOKEN end_char="1617" id="token-9-35" morph="none" pos="punct" start_char="1616">."</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>